Queen’s receives influx of funds for clinical cancer trials

May 23, 2019

The Canadian Cancer Trials Group at Queen’s University has received $25M from two American institutions with which it is collaborating. The Kingston Whig-Standard reports that the collaborations consist of clinical trials with volunteer cancer patients. The influx of funding will help more Canadian cancer patients participate in the trials, the Whig-Standard adds. “Clinical trials are hard to do if there’s only so many of these patients with these rare cancers, so if we collaborate more broadly we can get those types of trials done,” said Janet Dancey, Director of the Group. The partners aim to complete 60 to 70 trials with 400 to 500 Canadian participants over the funding period, which lasts for six years. Whig-StandardON